EP3661494
USE OF TASIMELTEON FOR THE TREATMENT OF AFFECTIVE DISORDERS IN MAJORITY BLACK AFRICAN PATIENTS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
2.8.2018EP published:
11.10.2023EP application number:
18755664.2
EPO information:
European Patent Register
Max expiry date:
1.8.2038
Title in English:
USE OF TASIMELTEON FOR THE TREATMENT OF AFFECTIVE DISORDERS IN MAJORITY BLACK AFRICAN PATIENTSLanguage of the patent:
English
Timeline
Today
2.8.2018EP application
11.10.2023EP Publication
Owner
Name:
Vanda Pharmaceuticals Inc.Address:
2200 Pennsylvania Ave NW Suite 300-E, Washington, DC 20037, US
Name:
Polymeropoulos, MihaelAddress:
10627 River's Bend Lane, Potomac, MD 20854, US
Name:
Polymeropoulos, ChristosAddress:
10627 River's Bend Lane, Potomac, MD 20854, US
Name:
Xiao, ChangfuAddress:
1235 Providence Terrace, McLean, VA 22101, US
Inventor
Name:
POLYMEROPOULOS, MihaelAddress:
Vienna VA 22182, US
Name:
POLYMEROPOULOS, ChristosAddress:
Vienna VA 22182, US
Name:
XIAO, ChangfuAddress:
McLean, VA 22101, US
Priority
Number:
201762540200 PDate:
2.8.2017Country:
US
Classification
Categories:
A61K 31/343, A61K 45/06, A61P 25/24